Vertex Pharmaceuticals Incorporated Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPITAL WORLD INVESTORS | 11/13/2024 | 26.81 M | $12.47 B | 0.38% | 10.39% |
| VANGUARD GROUP INC | 11/13/2024 | 23.16 M | $10.77 B | 0.80% | 8.98% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 21.79 M | $10.13 B | 100.00% | 8.44% |
| STATE STREET CORP | 11/14/2024 | 11.82 M | $5.50 B | 0.77% | 4.58% |
| FMR LLC | 11/13/2024 | 10.53 M | $4.89 B | -1.91% | 4.08% |
| CAPITAL RESEARCH GLOBAL INVESTORS | 11/13/2024 | 9.00 M | $4.19 B | 5.42% | 3.49% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2024 | 7.37 M | $3.43 B | 2.10% | 2.86% |
| JPMORGAN CHASE & CO | 11/08/2024 | 6.93 M | $3.22 B | 4.98% | 2.69% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 5.94 M | $2.75 B | -6.16% | 2.30% |
| JENNISON ASSOCIATES LLC | 11/08/2024 | 5.55 M | $2.58 B | 18.11% | 2.15% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 4.80 M | $2.23 B | 17.20% | 1.86% |
| AMUNDI | 11/13/2024 | 3.76 M | $1.73 B | 7.28% | 1.46% |
| LOOMIS SAYLES & CO L P | 11/13/2024 | 3.07 M | $1.43 B | -2.35% | 1.19% |
| MORGAN STANLEY | 11/14/2024 | 3.04 M | $1.41 B | -6.76% | 1.18% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11/12/2024 | 2.91 M | $1.35 B | 5.82% | 1.13% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 2.61 M | $1.21 B | 1.42% | 1.01% |
| JANUS HENDERSON GROUP PLC | 11/14/2024 | 2.52 M | $1.17 B | 4.14% | 0.98% |
| LEGAL & GENERAL GROUP PLC | 11/14/2024 | 2.30 M | $1.07 B | -4.91% | 0.89% |
| CLEARBRIDGE INVESTMENTS, LLC | 11/12/2024 | 1.97 M | $917.16 M | -5.68% | 0.76% |
| INVESCO LTD. | 11/12/2024 | 1.94 M | $903.93 M | 7.81% | 0.75% |
| AMERIPRISE FINANCIAL INC | 11/14/2024 | 1.87 M | $870.55 M | -8.90% | 0.73% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 1.79 M | $830.97 M | -2.77% | 0.69% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2024 | 1.77 M | $822.27 M | -20.06% | 0.69% |
| RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.63 M | $758.77 M | 4.16% | 0.63% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 1.63 M | $756.38 M | 1.27% | 0.63% |
| ROYAL BANK OF CANADA | 11/14/2024 | 1.57 M | $729.08 M | -6.78% | 0.61% |
| EDGEWOOD MANAGEMENT LLC | 11/12/2024 | 1.55 M | $719.19 M | 7,876.32% | 0.60% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 1.36 M | $631.83 M | -34.13% | 0.53% |
| HARDING LOEVNER LP | 11/14/2024 | 1.15 M | $536.08 M | -2.68% | 0.45% |
| DZ BANK AG DEUTSCHE ZENTRAL GENOSSENSCHAFTS BANK, FRANKFURT AM MAIN | 11/14/2024 | 1.04 M | $482.40 M | -4.95% | 0.40% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 11/13/2024 | 967,851 | $450.13 M | -4.37% | 0.38% |
| BARCLAYS PLC | 11/19/2024 | 939,336 | $436.86 M | 11.08% | 0.36% |
| VOYA INVESTMENT MANAGEMENT LLC | 11/14/2024 | 938,051 | $435.85 M | -36.73% | 0.36% |
| WELLS FARGO & COMPANY/MN | 11/13/2024 | 830,220 | $386.12 M | 1.45% | 0.32% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 789,220 | $367.05 M | -1.88% | 0.31% |
| UBS GROUP AG | 11/14/2024 | 774,215 | $360.07 M | 30.26% | 0.30% |
| SWISS NATIONAL BANK | 11/07/2024 | 766,000 | $356.25 M | 0.16% | 0.30% |
| SUMITOMO MITSUI TRUST HOLDINGS, INC. | 11/05/2024 | 672,098 | $312.58 M | 1.01% | 0.26% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 647,808 | $301.27 M | -2.29% | 0.25% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 11/13/2024 | 622,225 | $289.38 M | -1.79% | 0.24% |
| SWEDBANK AB | 10/11/2024 | 578,513 | $269.05 M | -13.16% | 0.22% |
| FIRST TRUST ADVISORS LP | 11/13/2024 | 575,032 | $267.44 M | 182.79% | 0.22% |
| BELLEVUE GROUP AG | 11/14/2024 | 571,406 | $265.75 M | -3.72% | 0.22% |
| BANK OF MONTREAL /CAN/ | 11/13/2024 | 557,217 | $257.92 M | 8.95% | 0.22% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2024 | 550,273 | $255.92 M | 6.77% | 0.21% |
| TD ASSET MANAGEMENT INC | 11/01/2024 | 522,205 | $241.72 M | 3.60% | 0.20% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/12/2024 | 518,003 | $240.48 M | -8.05% | 0.20% |
| NATIONAL PENSION SERVICE | 10/30/2024 | 511,047 | $237.68 M | 10.70% | 0.20% |
| DEKABANK DEUTSCHE GIROZENTRALE | 10/24/2024 | 506,457 | $233.37 M | 0.99% | 0.20% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2024 | 484,813 | $225.48 M | -17.31% | 0.19% |
Vertex Pharmaceuticals Incorporatedinstitutional Ownership - FAQ's
During the previous two years, 2018 institutional investors and hedge funds held shares of Vertex Pharmaceuticals Incorporated. The most heavily invested institutionals were:
Capital World Investors: 26.81 M
VANGUARD GROUP INC: 23.16 M
BlackRock Funding, Inc. /DE: 21.79 M
STATE STREET CORP: 11.82 M
FMR LLC: 10.53 M
Capital Research Global Investors: 9 M
89.70% of Vertex Pharmaceuticals Incorporated stock is owned by institutional investors.
Institutional investors have bought a total of 288.77 M shares in the last 24 months. This purchase volume represents approximately $118.25 B in transactions.